000 01413 a2200421 4500
005 20250517152417.0
264 0 _c20180423
008 201804s 0 0 eng d
022 _a1434-9949
024 7 _a10.1007/s10067-017-3664-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartínez-Martínez, Laura-Aline
245 0 0 _aAmbroxol for fibromyalgia: one group pretest-posttest open-label pilot study.
_h[electronic resource]
260 _bClinical rheumatology
_cAug 2017
300 _a1879-1884 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAmbroxol
_xtherapeutic use
650 0 4 _aAnalgesics
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aFibromyalgia
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPain Measurement
650 0 4 _aPilot Projects
650 0 4 _aTreatment Outcome
700 1 _aPérez, Luis-Fernando
700 1 _aBecerril-Mendoza, Lizbeth-Teresa
700 1 _aRodríguez-Henriquez, Pedro
700 1 _aMuñoz, Omar-Eloy
700 1 _aAcosta, Gumaro
700 1 _aSilveira, Luis H
700 1 _aVargas, Angélica
700 1 _aBarrera-Villalpando, María-Isabel
700 1 _aMartínez-Lavín, Manuel
773 0 _tClinical rheumatology
_gvol. 36
_gno. 8
_gp. 1879-1884
856 4 0 _uhttps://doi.org/10.1007/s10067-017-3664-z
_zAvailable from publisher's website
999 _c27136350
_d27136350